Do the policies outlined in the COVID-19 Transport Media Policy apply to commercial manufacturers of saline or phosphate-buffered saline (PBS) that can be used for specimen transport purposes?.Do the policies outlined in the COVID-19 Transport Media Policy apply to inactivating transport media (ITM)?.Do the policies outlined in the COVID-19 Transport Media Policy apply to formulations of viral transport media that differ from the CDC's SOP for the Preparation of Viral Transport Media?.Do the policies outlined in the COVID-19 Transport Media Policy apply to commercial manufacturers of viral transport media?.Do the policies outlined in the COVID-19 Transport Media Policy apply to all types of transport media?.Does transport media need to be sterile when used with COVID-19 molecular or antigen assays?.Which product codes are used for transport medium products?.On this page, this guidance is referred to as the COVID-19 Transport Media Policy.įor information regarding the development and performance of tests for SARS-CoV-2, please see the FAQs on Testing for SARS-CoV-2 webpage. This page includes questions and answers regarding the policies outlined in the Enforcement Policy for Viral Transport Media During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency. These questions and answers provide additional clarity on existing policies and do not introduce any new policies or modify any existing policies.
This page provides answers to frequently asked questions relating to the development and use of transport media during the COVID-19 public health emergency.
0 kommentar(er)
